Scientists have demonstrated a method for generating several key types of eye tissue from human stem cells in a way that mirrors whole eye development.
When transplanted to an animal model of corneal blindness, these tissues are shown to repair the front of the eye and restore vision, which scientists say could pave the way for human clinical trials of anterior eye transplantation to restore lost or damaged vision.
A collaborative team comprising researchers from Cardiff University and Osaka University in Japan describe their findings today (embargo: 18:00GMT, 09 March, 2016) in Nature.
The eye is composed of highly specialized tissues that are derived from a variety of cell lineages during development.
Previous studies have demonstrated that particular cell types, such as those that constitute the retina or cornea, can be created in the laboratory from pluripotent stem cells. However, these studies do not represent the complexity of whole eye development.
This latest study reports the generation of multiple cell lineages of the eye, including the lens, cornea, and conjunctiva, using human induced pluripotent stem cells.
The scientists have been able to show that the corneal epithelial cells can be cultivated and transplanted onto the eyes of rabbits with experimentally induced blindness to surgically repair the front of the eye.
Study co-author, Professor Andrew Quantock, said: “This research shows that various types of human stem cells are able to take on the characteristics of the cornea, lens and retina.
“Importantly, it demonstrates that one cell type – the corneal epithelium – could be further grown in the lab and then transplanted on to a rabbit’s eye where it was functional, achieving recovered vision.
“Our work not only holds potential for developing cells for treatment of other areas of the eye, but could set the stage for future human clinical trials of anterior eye transplantation to restore visual function.”
The Latest on: Stem cell transplantation
via Google News
The Latest on: Stem cell transplantation
- Dr. Jain on the Role of Allogeneic Transplant in Myelofibrosison March 23, 2020 at 12:08 pm
Tania Jain, MBBS, assistant professor of oncology, Division of Hematological Malignancies and Stem Cell Transplantation, Johns Hopkins University, discusses the role of allogeneic stem cell transplant ...
- Study Suggests Second Patient Cured from HIV Through Stem Cell Transplantationon March 23, 2020 at 9:01 am
A study of the second HIV patient to undergo successful stem cell transplantation from donors with an HIV-resistant gene found that there was no active viral infection in the patient’s blood 30 months ...
- Despite COVID-19 travel bans, stem cells arrive from Poland in time to treat Spokane leukemia patienton March 19, 2020 at 9:19 am
When travel bans apparently stalled medical transport of donor stem cells for her husband, Spokane resident Janet Terpko made calls all weekend to federal and foreign officials. On Monday, Terpko said ...
- Second person free from HIV after stem cell transplanton March 16, 2020 at 9:00 pm
The second person to undergo a successful stem cell transplant from a donor with an HIV-resistant gene has been cured.
- Treating sickle cell anemiaon March 12, 2020 at 11:46 am
Research on sickle cell anemia has again taken center stage because of new drug therapies, cures through stem cell transplantation, and the promise of gene therapy. Current treatment options focus ...
- Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalanon March 12, 2020 at 7:37 am
Fig. 1: Adjusted probabilities of leukemia-free and overall survival for all patients according to conditioning regimen. Fig. 2: Cumulative incidence of relapse according to conditioning regimen, ...
- Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantationon March 12, 2020 at 3:11 am
Avoiding immune rejection after allogeneic induced pluripotent stem cell-derived cardiomyocyte (iPSC-CM) transplantation is a concern. However, mesenchymal stem cells (MSCs) can suppress immune ...
- HIV patient appears to be totally cured after stem cell treatmenton March 11, 2020 at 8:17 pm
A stem cell transplant has rid a man of HIV, making him the second person to be declared cured of the virus. The transplant used stem cells that contained a unique mutation that works against HIV.
- 2nd person cured of HIV thanks to stem cell transplanton March 11, 2020 at 10:33 am
Researchers in the United Kingdom have confirmed that a stem cell transplant has cured a second person of HIV. Share on Pinterest Analyses confirm that a second person has now reached the stage at ...
- Second patient cured of HIV using stem cell transplant treatmenton March 10, 2020 at 10:43 pm
PARIS – A second patient has been cured of HIV after undergoing stem cell transplant treatment, doctors said Tuesday, after finding no trace of infection 30 months after he stopped traditional ...
via Bing News